|
|
xv | |
Preface |
|
xvii | |
|
Chapter 1 Why Health Economics? |
|
|
1 | (16) |
|
1.1 Why Health Economics? |
|
|
1 | (1) |
|
1.2 Economics as a Map for Decision-Making |
|
|
2 | (1) |
|
1.3 Special Challenges for Healthcare Managers |
|
|
3 | (3) |
|
1.3.1 Risk and Uncertainty |
|
|
4 | (1) |
|
|
4 | (1) |
|
1.3.3 Asymmetric Information |
|
|
5 | (1) |
|
1.3.4 Not-for-Profit Organizations |
|
|
5 | (1) |
|
1.3.5 Technological and Institutional Change |
|
|
6 | (1) |
|
1.4 Flux in the Healthcare System |
|
|
6 | (3) |
|
1.4.1 The Pressure to Reduce Costs |
|
|
7 | (1) |
|
1.4.2 The Fragmentation of Healthcare Payments |
|
|
8 | (1) |
|
1.5 What Does Economics Study? |
|
|
9 | (4) |
|
|
13 | (4) |
|
|
13 | (1) |
|
|
14 | (3) |
|
Chapter 2 An Overview of the US Healthcare System |
|
|
17 | (22) |
|
2.1 Input and Output Views of Healthcare |
|
|
17 | (3) |
|
|
18 | (2) |
|
|
20 | (1) |
|
|
20 | (2) |
|
2.3 Outputs of the Healthcare System |
|
|
22 | (3) |
|
2.3.1 Why Is How Much We Spend on Healthcare Interesting? |
|
|
22 | (1) |
|
2.3.2 Why Is Healthcare Spending Rising More Slowly than Anticipated? |
|
|
22 | (3) |
|
2.4 The Shifting Pattern of Healthcare Spending |
|
|
25 | (2) |
|
2.5 Disruptive Change in the Healthcare System |
|
|
27 | (6) |
|
2.5.1 Rapid Technological Change |
|
|
27 | (2) |
|
2.5.2 The Shrinking Share of Direct Consumer Payments |
|
|
29 | (1) |
|
2.5.3 Inadequacies of the Nation's Public Health Infrastructure |
|
|
29 | (1) |
|
2.5.4 The Nation's Poor Infant and Maternal Health Outcomes |
|
|
29 | (1) |
|
2.5.5 Significant Health Disparities Linked to Income and Ethnicity |
|
|
30 | (1) |
|
2.5.6 The Gradual Increase in the Share of Insured Americans |
|
|
30 | (1) |
|
2.5.7 The Transformation of the Health Insurance Industry |
|
|
30 | (3) |
|
|
33 | (6) |
|
|
33 | (2) |
|
|
35 | (4) |
|
Chapter 3 An Overview of the Healthcare Financing System |
|
|
39 | (18) |
|
|
39 | (3) |
|
3.1.1 Paying for Medical Care |
|
|
39 | (1) |
|
|
40 | (1) |
|
3.1.3 Sources of Insurance |
|
|
41 | (1) |
|
|
41 | (1) |
|
3.2 What Is Insurance, and Why Is It So Prevalent? |
|
|
42 | (4) |
|
3.2.1 What Insurance Does |
|
|
42 | (1) |
|
3.2.2 Adverse Selection and Moral Hazard |
|
|
42 | (2) |
|
3.2.3 Medicare as an Example of Complexity |
|
|
44 | (2) |
|
3.3 The Changing Nature of Health Insurance |
|
|
46 | (4) |
|
|
50 | (2) |
|
|
52 | (5) |
|
|
53 | (1) |
|
|
54 | (3) |
|
Chapter 4 Describing, Evaluating, and Managing Risk |
|
|
57 | (20) |
|
|
57 | (1) |
|
|
58 | (1) |
|
4.3 Dealing with Uncertainty |
|
|
58 | (1) |
|
4.4 Describing Potential Outcomes |
|
|
59 | (2) |
|
|
61 | (6) |
|
|
62 | (2) |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
4.5.5 Sensitivity Analysis |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
67 | (4) |
|
4.6.1 Contingency Planning |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (2) |
|
|
71 | (6) |
|
|
71 | (4) |
|
|
75 | (2) |
|
Chapter 5 Understanding Costs |
|
|
77 | (16) |
|
|
77 | (1) |
|
|
78 | (3) |
|
|
81 | (2) |
|
5.4 Factors That Influence Costs |
|
|
83 | (3) |
|
|
83 | (2) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
5.5 Variable and Fixed Costs |
|
|
86 | (1) |
|
|
87 | (6) |
|
|
88 | (2) |
|
|
90 | (3) |
|
Chapter 6 Improving Population Health |
|
|
93 | (24) |
|
|
93 | (2) |
|
|
95 | (1) |
|
6.2.1 Standardization of Dependent Care Coverage |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
96 | (1) |
|
6.3 Addition of New Insurance Benefits |
|
|
96 | (1) |
|
6.3.1 The Oregon Experiments |
|
|
96 | (1) |
|
6.3.2 Medicare Enhancements |
|
|
97 | (1) |
|
6.3.3 Private Insurance Enhancements |
|
|
97 | (1) |
|
6.4 Alternative Payment Systems |
|
|
97 | (5) |
|
6.4.1 Accountable Care Organizations |
|
|
97 | (1) |
|
|
98 | (1) |
|
6.4.3 Reference Pricing and Centers of Excellence |
|
|
98 | (1) |
|
6.4.4 Second Opinion Programs |
|
|
99 | (1) |
|
6.4.5 Value-Based Pricing |
|
|
99 | (3) |
|
6.5 New Organizational Structures |
|
|
102 | (2) |
|
6.5.1 Patient-Centered Medical Homes |
|
|
102 | (1) |
|
|
103 | (1) |
|
6.6 Focus on Population Health |
|
|
104 | (1) |
|
6.7 Improving Population Health |
|
|
105 | (3) |
|
6.7.1 Social Determinants of Health |
|
|
105 | (1) |
|
6.7.2 What Are Modifiable Social Determinants of Health? |
|
|
106 | (2) |
|
|
108 | (9) |
|
|
110 | (1) |
|
|
111 | (6) |
|
Chapter 7 The Demand for Healthcare Products |
|
|
117 | (18) |
|
|
117 | (2) |
|
|
118 | (1) |
|
7.1.2 Indirect Payments and Insurance |
|
|
118 | (1) |
|
7.2 Why Demand for Healthcare Is Complex |
|
|
119 | (1) |
|
7.3 Demand Without Insurance and Healthcare Professionals |
|
|
120 | (3) |
|
|
120 | (2) |
|
7.3.2 Factors Other than Price |
|
|
122 | (1) |
|
7.4 Demand with Insurance |
|
|
123 | (3) |
|
7.5 Demand with Advice from Providers |
|
|
126 | (3) |
|
|
129 | (6) |
|
|
129 | (3) |
|
|
132 | (3) |
|
|
135 | (12) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
137 | (1) |
|
8.4 Price Elasticities of Demand |
|
|
137 | (3) |
|
|
140 | (1) |
|
|
140 | (2) |
|
|
142 | (5) |
|
|
143 | (2) |
|
|
145 | (2) |
|
|
147 | (18) |
|
|
147 | (1) |
|
9.2 What Is a Sales Forecast? |
|
|
148 | (3) |
|
|
151 | (5) |
|
|
156 | (2) |
|
|
158 | (7) |
|
|
159 | (3) |
|
|
162 | (3) |
|
Chapter 10 Supply and Demand Analysis |
|
|
165 | (18) |
|
|
165 | (3) |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (1) |
|
10.1.4 Professional Advice and Imperfect Competition |
|
|
168 | (1) |
|
10.2 Demand and Supply Shifts |
|
|
168 | (4) |
|
|
170 | (1) |
|
|
171 | (1) |
|
10.3 Shortage and Surplus |
|
|
172 | (3) |
|
10.4 Analyses of Multiple Markets |
|
|
175 | (1) |
|
|
175 | (8) |
|
|
176 | (6) |
|
|
182 | (1) |
|
Chapter 11 Maximizing Profits |
|
|
183 | (16) |
|
|
183 | (1) |
|
11.2 Cutting Costs to Increase Profits |
|
|
184 | (3) |
|
11.2.1 Cost Reduction Through Improved Clinical Management |
|
|
185 | (2) |
|
|
187 | (1) |
|
|
187 | (2) |
|
11.4 Return on Investment |
|
|
189 | (1) |
|
11.5 Producing to Stock or to Order |
|
|
190 | (1) |
|
11.6 Not-for-Profit Organizations |
|
|
191 | (3) |
|
|
191 | (1) |
|
11.6.2 Differences in Goals |
|
|
191 | (1) |
|
11.6.3 Differences in Costs |
|
|
192 | (2) |
|
|
194 | (5) |
|
|
194 | (3) |
|
|
197 | (2) |
|
|
199 | (14) |
|
|
199 | (1) |
|
12.2 The Economic Model of Pricing |
|
|
200 | (1) |
|
|
201 | (2) |
|
12.4 Price Discrimination |
|
|
203 | (3) |
|
|
206 | (1) |
|
12.6 Pricing and Managed Care |
|
|
206 | (2) |
|
|
208 | (5) |
|
|
208 | (4) |
|
|
212 | (1) |
|
Chapter 13 Asymmetric Information and Incentives |
|
|
213 | (20) |
|
13.1 Asymmetric Information |
|
|
213 | (1) |
|
|
214 | (2) |
|
13.2.1 Remedies for Asymmetric Information |
|
|
215 | (1) |
|
13.2.2 The Special Challenges for Healthcare |
|
|
215 | (1) |
|
|
216 | (1) |
|
13.3 Incentive Design for Providers |
|
|
216 | (5) |
|
13.4 Insurance and Incentives |
|
|
221 | (1) |
|
13.5 Limits on Incentive-Based Payments |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
222 | (1) |
|
|
223 | (1) |
|
|
223 | (1) |
|
13.6 Incentive Design for Managers |
|
|
223 | (4) |
|
|
227 | (6) |
|
|
227 | (3) |
|
|
230 | (3) |
|
Chapter 14 Economic Analysis of Clinical and Managerial Interventions |
|
|
233 | (18) |
|
|
233 | (2) |
|
|
235 | (2) |
|
14.2.1 Identifying a Cost Perspective |
|
|
235 | (1) |
|
14.2.2 Identifying Resources and Opportunity Costs |
|
|
236 | (1) |
|
14.2.3 Direct and Indirect Costs |
|
|
236 | (1) |
|
|
237 | (1) |
|
14.4 Cost-Minimization Analysis |
|
|
238 | (1) |
|
14.5 Cost-Effectiveness Analysis |
|
|
239 | (1) |
|
14.6 Cost-Benefit Analysis |
|
|
240 | (3) |
|
14.7 Cost-Utility Analysis |
|
|
243 | (3) |
|
|
246 | (5) |
|
|
247 | (2) |
|
|
249 | (2) |
|
Chapter 15 Profits, Market Structure, and Market Power |
|
|
251 | (20) |
|
|
251 | (2) |
|
15.2 Rivalry Among Existing Firms |
|
|
253 | (1) |
|
15.3 Defining Market Structures |
|
|
254 | (1) |
|
15.4 Customers' Bargaining Power |
|
|
255 | (1) |
|
15.5 The Bargaining Power of Suppliers |
|
|
256 | (1) |
|
15.6 Entry by Potential Rivals |
|
|
257 | (2) |
|
15.7 Market Structure and Markups |
|
|
259 | (2) |
|
|
259 | (1) |
|
15.7.2 The Impact of Market Structure on Prices |
|
|
260 | (1) |
|
15.8 Market Power and Profits |
|
|
261 | (6) |
|
|
261 | (2) |
|
15.8.2 Product Differentiation and Advertising |
|
|
263 | (4) |
|
|
267 | (4) |
|
|
267 | (2) |
|
|
269 | (2) |
|
Chapter 16 Government Intervention in Healthcare Markets |
|
|
271 | (20) |
|
16.1 Government Intervention in Healthcare |
|
|
272 | (3) |
|
16.1.1 On the Virtues of Markets |
|
|
272 | (1) |
|
16.1.2 Information Processing |
|
|
272 | (2) |
|
16.1.3 Static Resource Allocation |
|
|
274 | (1) |
|
16.1.4 Dynamic Resource Allocation |
|
|
275 | (1) |
|
|
275 | (8) |
|
|
276 | (2) |
|
|
278 | (3) |
|
16.2.3 Imperfect Competition |
|
|
281 | (1) |
|
16.2.4 Imperfect Information and Incomplete Markets |
|
|
281 | (2) |
|
|
283 | (1) |
|
16.2.6 Income Redistribution |
|
|
283 | (1) |
|
|
283 | (3) |
|
16.3.1 Assignment of Property Rights |
|
|
284 | (1) |
|
16.3.2 Taxes and Subsidies |
|
|
285 | (1) |
|
|
285 | (1) |
|
|
286 | (1) |
|
|
286 | (5) |
|
|
287 | (2) |
|
|
289 | (2) |
|
|
291 | (16) |
|
|
291 | (1) |
|
17.2 Market Imperfections |
|
|
292 | (2) |
|
|
293 | (1) |
|
|
293 | (1) |
|
|
293 | (1) |
|
17.3 Rational Consumer Ignorance |
|
|
294 | (1) |
|
17.4 The Interest Group Model of Regulation |
|
|
295 | (2) |
|
17.4.1 Limiting Competition |
|
|
296 | (1) |
|
|
296 | (1) |
|
17.4.3 Regulation as a Competitive Strategy |
|
|
296 | (1) |
|
17.5 Regulatory Imperfections |
|
|
297 | (2) |
|
17.5 Market Responses to Market Imperfections |
|
|
299 | (3) |
|
17.5.1 Tort Law and Contract Law |
|
|
299 | (1) |
|
17.5.2 Information Dissemination |
|
|
300 | (1) |
|
|
301 | (1) |
|
|
302 | (5) |
|
|
303 | (2) |
|
|
305 | (2) |
|
Chapter 18 Behavioral Economics |
|
|
307 | (16) |
|
|
307 | (1) |
|
18.2 Inconsistent Preferences |
|
|
308 | (2) |
|
|
310 | (1) |
|
|
311 | (2) |
|
18.5 Representativeness and the Law of Small Numbers |
|
|
313 | (1) |
|
18.6 Inconsistent Decision-Making: Framing |
|
|
314 | (3) |
|
|
317 | (6) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (4) |
Glossary |
|
323 | (10) |
Index |
|
333 | (22) |
About the Author |
|
355 | |